Efficacy and Safety of Serplulimab With Chemotherapy and Aspirin in Untreated Extensive-Stage Small Cell Lung Cancer

Name: Efficacy and Safety of Serplulimab With Chemotherapy and Aspirin in Untreated Extensive-Stage Small Cell Lung Cancer
License: Public Domain

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

extensive-stage small cell lung cancer, treatment-naïve for systemic therapy targeting extensive-stage small cell lung cancer, ecog performance status score of 0 or 1, expected survival ≥3 months

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 429744
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.